Trial intelligence / Profile preview

Lidocaine and ketamine infusion strategies for intraoperative neuromonitoring in spine surgery

IRCT20230204057318N2Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Back disorder comparing Ketamine infusion, Lidocaine infusion and Simultaneous lidocaine + ketamine infusion (3 arms). Primary endpoints: Latency changes in neuromonitoring and Amplitude changes in neuromonitoring. Started Jul 2023; status: completed.

02

Drugs

lidocaineketamine
03

Conditions

Back disorder

Beyond the preview

Go deeper on IRCT20230204057318N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230204057318N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call